C-J Advisory’s Celgene Corp CELG Stock Holding History

C-J Advisory’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-189	Closed	-$17K	–	174
2019 Q2	$17K	Hold	189	–	–	0.01%	108
2019 Q1	$18K	Hold	189	–	–	0.01%	119
2018 Q4	$12K	Hold	189	–	–	0.01%	105
2018 Q3	$17K	Hold	189	–	–	0.01%	94
2018 Q2	$15K	Hold	189	–	–	0.01%	102
2018 Q1	$16K	Hold	189	–	–	0.01%	94
2017 Q4	$20K	Buy	189 +61	+48%	+$6.88K	0.01%	77
2017 Q3	$19K	Hold	128	–	–	0.01%	80
2017 Q2	$17K	Hold	128	–	–	0.01%	86
2017 Q1	$16K	Hold	128	–	–	0.01%	90
2016 Q4	$15K	Hold	128	–	–	0.01%	93
2016 Q3	$13K	Buy	+128	New	+$13.9K	0.01%	100

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

C-J Advisory's CELG Position: Q3 2019 in Review

C-J Advisory sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 189 shares — an estimated $17K sold.

C-J Advisory first reported a position in CELG in Q3 2016 and held it in 12 quarters. The position peaked at $20K in Q4 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

C-J Advisory reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
C-J Advisory sold 189 Celgene Corp shares in Q3 2019, an estimated $17K.
C-J Advisory first reported a position in Celgene Corp in Q3 2016 and held it in 12 quarters.
C-J Advisory's Celgene Corp position peaked at $20K in Q4 2017.
1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on C-J Advisory's 13F filing for Q3 2019, filed 9 Oct 2019.